Kansino: A Single-Dose COVID-19 Vaccine
The COVID-19 pandemic has caused millions of deaths and disrupted the lives of billions of people around the world. To combat the virus, several vaccines have been developed and authorized for use in different countries. One of these vaccines is kansino, a single-dose vaccine that is manufactured by CanSino Biologics, a Chinese biopharmaceutical company.
What is kansino and what type of vaccine is it?
Kansino, also known as Convidecia or Ad5-nCoV, is a recombinant vaccine that uses a modified human adenovirus as a vector to deliver the genetic code of the spike protein of SARS-CoV-2, the virus that causes COVID-19. The adenovirus is harmless and cannot replicate in human cells, but it can trigger an immune response that produces antibodies and T cells that can recognize and fight the coronavirus. Kansino is administered as a single dose of 0.5 mL by intramuscular injection into the deltoid muscle of the upper arm.
kansino
How effective is kansino against COVID-19 and its variants?
According to clinical trial data reviewed by the World Health Organization (WHO), kansino has an efficacy of 58% against symptomatic disease and 92% against severe COVID-19. The vaccine also showed some protection against the Alpha and Beta variants of the virus, but its effectiveness against other variants, such as Delta, is still under investigation. The WHO has issued an emergency use listing (EUL) for kansino, which means that it meets the standards of safety, efficacy and quality for COVID-19 vaccines.
What are the possible side effects of kansino and who should not take it?
Like any vaccine, kansino may cause some mild to moderate side effects in some people, such as pain at the injection site, fever, fatigue, headache, muscle pain, chills and diarrhea. These side effects usually go away within a few days and do not require medical attention. However, some people may have an allergic reaction or a rare blood clotting disorder after receiving the vaccine. Therefore, anyone who has a history of anaphylaxis to any component of the vaccine or who experienced thrombotic thrombocytopenic syndrome (TTS) following the first dose should not receive kansino. People who have acute PCR-confirmed COVID-19 should also wait until they recover before getting vaccinated.
Which countries have approved kansino and where can people get it?
Kansino has been approved for use in several countries, including China, Pakistan, Mexico, Argentina, Chile, Ecuador and Hungary. The vaccine is also part of the COVAX facility, which aims to provide equitable access to COVID-19 vaccines for low- and middle-income countries. People who are interested in getting vaccinated with kansino should check with their local health authorities for availability and eligibility.
Conclusion
Kansino is a single-dose COVID-19 vaccine that uses a modified human adenovirus as a vector to deliver the genetic code of the spike protein of SARS-CoV-2. The vaccine has an efficacy of 58% against symptomatic disease and 92% against severe COVID-19. It also has a favorable safety profile and can be stored at normal refrigeration temperatures. Kansino has been approved for use in several countries and is part of the COVAX facility. However, its effectiveness against new variants of the virus is still under investigation.
kansino online casino
kansino live casino
kansino roulette
kansino blackjack
kansino video slots
kansino jackpots
kansino arcade games
kansino megaways
kansino exclusieve spellen
kansino klassieke gokkasten
kansino tafel spellen
kansino populaire games
kansino nieuwe games
kansino game collecties
kansino hoofdpartner van AZ Alkmaar
kansino veilig vertrouwd
kansino bonus aanbiedingen
kansino loyaliteitsprogramma
kansino klantenservice
kansino betaalmethoden
kansino uitbetalingen
kansino verantwoord spelen
kansino registreren
kansino inloggen
kansino account verifiëren
kansino mobiel spelen
kansino app downloaden
kansino nieuwsbrief ontvangen
kansino ervaringen en reviews
kansino veelgestelde vragen
kansino contact opnemen
kansino algemene voorwaarden
kansino privacy beleid
kansino cookie beleid
kansino spelregels en uitleg
kansino spelproviders en partners
kansino licentie en regulering
kansino klachten en geschillen
kansino promoties en acties
kansino gratis spelen
kansino voor echt geld spelen
kansino minimale en maximale inzetten
kansino uitkeringspercentages en RTP's
kansino winnaars en testimonials
kansino tips en strategieën
kansino blog en artikelen
kansino social media volgen
kansino vacatures en carrière
FAQs
Can I get COVID-19 from kansino?
No, you cannot get COVID-19 from kansino because it does not contain live or weakened virus.
Do I need a booster dose of kansino?
Do I need a booster dose of kansino?
The duration of protection from kansino is still unknown. However, some studies have suggested that using kansino as a booster dose after a primary series with another COVID-19 vaccine may enhance the immune response and provide better protection against emerging variants of the virus . The WHO recommends that kansino may be used as a booster dose following a completed primary series using any other EUL COVID-19 vaccine. However, the optimal timing and interval of the booster dose are still under investigation. Therefore, people who have received kansino as their primary vaccine should follow the guidance of their local health authorities regarding the need and availability of a booster dose.
How can I report any adverse events after vaccination?
It is important to monitor and report any adverse events that may occur after vaccination, as this helps to ensure the safety and effectiveness of the vaccine. If you experience any side effects or health problems after receiving kansino, you should contact your health care provider or report them to the national pharmacovigilance system in your country. You can also use the VigiAccess website, which is a global database of adverse drug reactions maintained by the WHO. By reporting any adverse events, you can contribute to the global knowledge and evidence on COVID-19 vaccines.
How can I find more information about kansino?
If you want to learn more about kansino, you can visit the official website of CanSino Biologics, which provides information about the vaccine's development, production, clinical trials, and global distribution. You can also check the WHO website, which provides updated interim policy recommendations, product information, and assessment reports on kansino and other COVID-19 vaccines. Additionally, you can consult your health care provider or local health authorities for any questions or concerns you may have about getting vaccinated with kansino.
How does kansino compare to other COVID-19 vaccines?
Kansino is one of several COVID-19 vaccines that have been authorized for use by the WHO and other regulatory agencies. Each vaccine has its own advantages and disadvantages in terms of efficacy, safety, storage, administration, availability, and cost. However, all vaccines are expected to provide a high level of protection against severe COVID-19 and reduce the risk of hospitalization and death. Therefore, the best vaccine is the one that is available and accessible to you. You should not wait for a specific vaccine or refuse a vaccine that is offered to you. Getting vaccinated as soon as possible is the best way to protect yourself and others from COVID-19.
What are some myths and facts about kansino?
There are many myths and misconceptions about COVID-19 vaccines in general and kansino in particular. Here are some common ones and the facts that debunk them:
MythFact
Kansino can alter your DNA.Kansino cannot alter your DNA because it does not enter the nucleus of your cells where your DNA is stored. It only delivers the genetic code of the spike protein of SARS-CoV-2 to your cells, which then produce this protein to stimulate your immune system.
Kansino can give you COVID-19.Kansino cannot give you COVID-19 because it does not contain live or weakened virus. It only contains a harmless adenovirus that cannot replicate in human cells.
Kansino contains harmful ingredients such as mercury or fetal tissue.Kansino does not contain any harmful ingredients such as mercury or fetal tissue. It only contains purified components that are necessary for its function and safety. You can find the list of ingredients on the product label or on the WHO website.
Kansino is not effective against new variants of SARS-CoV-2.Kansino has shown some protection against the Alpha and Beta variants of SARS-CoV-2 in clinical trials. However, its effectiveness against other variants such as Delta is still under investigation. More studies are needed to determine how well kansino works against new variants over time.
Kansino is not safe because it was developed too fast.Kansino is safe because it was developed following rigorous scientific standards and ethical principles. It was tested in large-scale clinical trials involving thousands of volunteers from different countries and age groups. It was also reviewed by independent experts and regulatory agencies before being authorized for use.
44f88ac181